Files
Download Full Text (802 KB)
Description
• Clinical trials are essential for advancing treatments in ophthalmology, yet comprehensive data on institutional participation in Phase 3 retina trials is not readily available.
• The U.S. National Library of Medicine Clinical Trials database (NLM database) lists individual research sites for each study; however, aggregating and visualizing this data remains challenging.
• The lack of centralized and easily interpretable data on research site participation hinders understanding of institutional contributions to retinal clinical research.
• Identifying geographic and institutional trends can improve resource allocation and research collaboration.
• We aim to
• Quantify the number of unique institutions participating in Phase 3 clinical retina trials.
• Assess the distribution of trials across research sites.
• Analyze state-level variations in participation.
• Hypothesis
• Institutional participation in Phase 3 retina trials is unevenly distributed, with a concentration in certain geographic regions and academic centers.
• Understanding trial site distribution can inform funding decisions, improve patient access to clinical trials, and guide future research efforts.
• Findings may help stakeholders optimize trial site selection and enhance equity in ophthalmic research participation.
Publication Date
5-2025
Keywords
Clinical trials, ophthalmology
Disciplines
Ophthalmology
Recommended Citation
Naseer S, Hassan T. A quantitative analysis on the locations of phase 3 retina trials in the United States over the past 5 Years. Poster presented at: Oakland University William Beaumont School of Medicine Embark Capstone Colloquium; 2025 May; Rochester Hills, MI.
Comments
The Embark Capstone Colloquium at the Oakland University William Beaumont School of Medicine, Rochester Hills, MI, May, 2025.